Accuray Inc (ARAY) stock
ARAYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
$2.50+0.06 (+2.46%)
Close on Nov 18, 2026Market cap $298.60MP/E –Yield –
Accuray revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Accuray's revenue for the twelve months ending Jun 30, 2026 was $401.95M, down 12.3% year over year. For fiscal 2026 it was $401.95M, down 12.3% from the year before. Over ten years it grew 0.1% a year on average. The highest annual figure on record is $458.51M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $401.95M | -12.3% |
| FY2025 | Jun 30, 2025 | $458.51M | +2.7% |
| FY2024 | Jun 30, 2024 | $446.55M | -0.2% |
| FY2023 | Jun 30, 2023 | $447.61M | +4.1% |
| FY2022 | Jun 30, 2022 | $429.91M | +8.5% |
| FY2021 | Jun 30, 2021 | $396.29M | +3.5% |
| FY2020 | Jun 30, 2020 | $382.93M | -8.6% |
| FY2019 | Jun 30, 2019 | $418.79M | +3.4% |
| FY2018 | Jun 30, 2018 | $404.90M | +5.6% |
| FY2017 | Jun 30, 2017 | $383.41M | -3.9% |
| FY2016 | Jun 30, 2016 | $398.80M | +5.0% |
| FY2015 | Jun 30, 2015 | $379.80M | +2.8% |
| FY2014 | Jun 30, 2014 | $369.42M | +16.9% |
| FY2013 | Jun 30, 2013 | $315.97M | -22.8% |
| FY2012 | Jun 30, 2012 | $409.22M | +84.1% |
| FY2011 | Jun 30, 2011 | $222.28M | +0.3% |
| FY2010 | Jun 30, 2010 | $221.63M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $100.92M | -20.9% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $104.85M | -7.4% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $102.24M | -12.0% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $93.94M | -7.5% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $127.54M | -5.0% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $113.24M | +12.0% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $116.17M | +8.3% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $101.55M | -2.3% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $134.29M | +13.5% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $101.13M | -14.3% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $107.24M | -6.6% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $103.89M | +7.7% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $118.29M | +7.5% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $118.06M | +22.8% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $114.76M | -1.3% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $96.49M | -10.2% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $110.02M | -0.8% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $96.17M | -6.2% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $116.28M | +19.3% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $107.44M | +25.9% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $110.94M | +16.8% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $102.56M | +3.0% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $97.46M | -1.4% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $85.33M | -4.7% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $94.98M | -19.1% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $99.55M | -3.6% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $98.83M | -3.4% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $89.58M | -6.5% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $117.42M | +3.2% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $103.22M | +13.5% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $102.32M | -8.7% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $95.83M | -1.5% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $113.79M | +30.0% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $90.95M | +5.1% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $112.09M | +18.0% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $97.31M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $87.50M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $86.51M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $94.97M | – |
See a number that looks wrong?